FDA Approves 18-Month Shelf Life For TAXUS(R) Stent System

Sat, 20 Jan 2007 02:00 PM EST

... Boston Scientific Corporation (NYSE: BSX) today announced that the U.S. Food and Drug Administration (FDA) has approved extending the shelf life of its TAXUS(R) Express(2)(TM) paclitaxel-eluting coronary stent system in the United States to 18 months from the current shelf life of 12 months. [click link for full article] ...